Alamar blue assays showed that overexpression of JMJD6 partially reversed the reduction in the number of viable neuroblastoma cells after treatment with THZ1 and panobinostat combination therapy (Fig. 7c). The gene discussed is JMJD6; the disease is neuroblastoma.